Physician

Brian Takemoto Kim, M.D.

According to 2025 Medicare claims, Brian Kim, M.D. (NPI: 1477713030) practices ophthalmology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is HARVARD EYE ASSOCIATES (NPI: 1356371074; TIN: 953873981) and primary practice location at 92653-3625.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,342 traditional Medicare patients, billed 45,342 HCPCS/CPT codes, and received $2,859,978 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 636 prescription claims across 221 beneficiaries totaling $79,489 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 18 records totaling $467. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,024,657 to $2,859,978. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $38,516 to $79,489. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $1,024,657 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,522,705 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,928,393 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,944,801 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,252,225 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,312,859 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,704,850 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,756,108 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,683,829 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,859,978 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159327,228$1,024,657
20161,1519,329$1,522,705
20171,24411,031$1,928,393
20181,42111,048$1,944,801
20191,73111,812$2,252,225
20202,06612,094$2,312,859
20212,40013,686$2,704,850
20222,32918,413$2,756,108
20232,25537,696$2,683,829
20242,34245,342$2,859,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$43K$86K2015 Drug cost: $38,516 (USD; Tot_Drug_Cst)2016 Drug cost: $38,857 (USD; Tot_Drug_Cst)2017 Drug cost: $32,880 (USD; Tot_Drug_Cst)2018 Drug cost: $23,044 (USD; Tot_Drug_Cst)2019 Drug cost: $52,452 (USD; Tot_Drug_Cst)2020 Drug cost: $64,531 (USD; Tot_Drug_Cst)2021 Drug cost: $55,952 (USD; Tot_Drug_Cst)2022 Drug cost: $67,130 (USD; Tot_Drug_Cst)2023 Drug cost: $85,932 (USD; Tot_Drug_Cst)2024 Drug cost: $79,489 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015123329$38,516
2016106276$38,857
201796270$32,880
201888247$23,044
2019131366$52,452
2020157446$64,531
2021132340$55,952
2022157420$67,130
2023171483$85,932
2024221636$79,489

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2891,293$106
92014Established patient complete exam of visual system465812$101
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,2861,724$96
99442Telephone medical discussion with physician, 11-20 minutes1,0151,062$62
92134Imaging of retina1,4222,775$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium662,046$25,152
DifluprednateDifluprednate1163,913$11,422
Bromfenac SodiumBromfenac Sodium391,399$7,428
CombiganBrimonidine Tartrate/Timolol151,025$5,996
Alphagan PBrimonidine Tartrate14485$3,773

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$467Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Brian Takemoto Kim, M.D.?

Tedicare shows public-source Medicare data for Brian Takemoto Kim, M.D. (NPI 1477713030), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian Takemoto Kim, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian Takemoto Kim, M.D.?

Brian Takemoto Kim, M.D. is linked to HARVARD EYE ASSOCIATES (billing NPI 1356371074) in the available physician profile data.

Does Brian Takemoto Kim, M.D. have Open Payments data?

Brian Takemoto Kim, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.